Neus Falgàs and Laura Mezquita join the Clínic-IDIBAPS 50/50 Programme
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
Both professionals will pursue a clinician-scientist career pathway, dividing their time equally between clinical care and research.
The Spanish Cancer Association, through its Scientific Foundation, has joined the Governing Board of the Clínic Barcelona Comprehensive Cancer Cent...
The Drug Desensitization Team within the Allergy Department has grown from performing four to five procedures per year in 2012 to nearly 500 today,...
This is the largest study in this field worldwide and was led by the Liver Oncology Unit (BCLC) at Clínic-IDIBAPS, within the Clínic Barcelona Comp...
A study from Clínic-IDIBAPS published in Hemasphere provides a comprehensive molecular characterization of a rare tumour.
Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, kno...
Hospital Clínic Barcelona has marked the 50th anniversary of the first allogeneic bone marrow transplant performed at the centre on June 12, 1976,...
Dr. Miquel Lozano Molero has been appointed President of the World Apheresis Association (WAA) for the 2026–2028 term. The election took place duri...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...
This European recognition endorses centres that integrate cancer care, research, education and innovation under the most demanding quality standards.